TMCnet News

Worldwide Clinical Trials Receives First Annual 2017 Medidata Accelerator Award
[November 30, 2017]

Worldwide Clinical Trials Receives First Annual 2017 Medidata Accelerator Award


Worldwide Clinical Trials (www.worldwide.com) has been recognized by Medidata (NASDAQ: MDSO), the leading global provider of cloud-based solutions and data analytics for clinical research, with the first annual Medidata Accelerator Award.

The award recognizes a CRO that demonstrates a shared commitment to helping customers drive clinical success and through industry relationships, promotes the advancement and acceleration of clinical trial execution.

"We are delighted to be recognized by Medidata with their inaugural Accelerator Award - an honor that belongs to all Worldwide team members and their shared commitment to embracing an innovative mindset and a laser focus on delivering uncommon value for trial sponsors," said Peter Benton, president and COO at Worldwide Clinical Trials.

"We're pleased to distinguish the great work of Worldwide Clinical Trials with this award," said April Mulroney, Managing Director of Payments at Medidata. "While this reflects their 2017 success, Worldwide Clinical Trials has proven to be a beacon for excellence in clinical research throughout our multi-year relationship. Medidata prioritizes timeliness and accuracy in payments, both critical to clinical research success, and we're proud to help Worldwide create an industry-leading site payment operation."

In July 2017, Worldwide Clinical Trials selected Medidata Payments Cloud to streamline accurate, timely payments on behalf of their clinical trial sponsors. Driven by EC Rave, Medidata Payment Cloud stood out as a truly end-to-end solution with full support for global tax calculations and disbursements to ensure the expenditure of payments directly into an investigative site's bank account. These capabilities will further enable Worldwide to transform the CRO experience for sponsors and sites -shortening payment cycle times, increasing accuracy and eliminating hours allocated to reconciliation and reporting.



Medidata NEXT Global was a three-day conference that included 89 thought-provoking sessions highlighting cutting-edge innovation within each phase of the clinical development cycle. Anthony Doyle, CFO of Worldwide Clinical Trials, accepted the award on the company's behalf.

For further information about Worldwide Clinical Trials, please visit Worldwide.com


Connect with Worldwide Clinical Trials:

Tweet: @Worldwidetrials receives the 2017 @Medidata Accelerator Award

Follow us on Twitter (News - Alert): @worldwidetrials

Find us on LinkedIn: https://www.linkedin.com/company/worldwide-clinical-trials-inc-

About Worldwide Clinical Trials

Worldwide Clinical Trials employs more than 1,600 professionals around the world, with offices in North and South America, Eastern and Western Europe, Russia and Asia. Founded by physicians committed to advancing medical science, Worldwide is out to change how the world experiences CROs - in the best possible way. From Early Phase and Bioanalytical Sciences through Late Phase and post approval, we provide world-class, full-service drug development services. With infrastructure and talent spanning 60 countries, we execute predictable, successful studies with operational excellence. We never compromise on science or safety. We're never satisfied with the status quo. We're the Cure for the Common CRO. For more information, visit Worldwide.com.

About Medidata

Medidata is reinventing global drug and medical device development by creating the industry's leading cloud-based solutions for clinical research. Through our advanced applications and intelligent data analytics, Medidata helps advance the scientific goals of life sciences customers worldwide, including over 950 global pharmaceutical companies, biotech, diagnostic and device firms, leading academic medical centers, and contract research organizations.

The Medidata Clinical Cloud® brings a new level of quality and efficiency to clinical trials that empower our customers to make more informed decisions earlier and faster. Our unparalleled clinical trial data assets provide deep insights that pave the way for future growth. The Medidata Clinical Cloud is the primary technology solution powering clinical trials for 18 of the world's top 25 global pharmaceutical companies and is used by 18 of the top 25 medical device developers-from study design and planning through execution, management and reporting.


[ Back To TMCnet.com's Homepage ]